16-21678250-A-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_144672.4(OTOA):​c.-4-261A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0235 in 152,100 control chromosomes in the GnomAD database, including 76 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.023 ( 76 hom., cov: 31)

Consequence

OTOA
NM_144672.4 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.0630

Publications

0 publications found
Variant links:
Genes affected
OTOA (HGNC:16378): (otoancorin) The protein encoded by this gene is specifically expressed in the inner ear, and is located at the interface between the apical surface of the inner ear sensory epithelia and their overlying acellular gels. It is prposed that this protein is involved in the attachment of the inner ear acellular gels to the apical surface of the underlying nonsensory cells. Mutations in this gene are associated with autosomal recessive deafness type 22 (DFNB22). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
OTOA Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 22
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Laboratory for Molecular Medicine, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 16-21678250-A-T is Benign according to our data. Variant chr16-21678250-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 1205134.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0235 (3567/152100) while in subpopulation NFE AF = 0.0359 (2442/67994). AF 95% confidence interval is 0.0347. There are 76 homozygotes in GnomAd4. There are 1662 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 76 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOANM_144672.4 linkc.-4-261A>T intron_variant Intron 1 of 28 ENST00000646100.2 NP_653273.3 Q05BM7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOAENST00000646100.2 linkc.-4-261A>T intron_variant Intron 1 of 28 NM_144672.4 ENSP00000496564.2 Q7RTW8-5
OTOAENST00000647277.1 linkn.-4-261A>T intron_variant Intron 1 of 28 ENSP00000495594.1 A0A2R8YG28

Frequencies

GnomAD3 genomes
AF:
0.0235
AC:
3568
AN:
151982
Hom.:
76
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00522
Gnomad AMI
AF:
0.160
Gnomad AMR
AF:
0.0150
Gnomad ASJ
AF:
0.0320
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0124
Gnomad FIN
AF:
0.0297
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0359
Gnomad OTH
AF:
0.0192
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0235
AC:
3567
AN:
152100
Hom.:
76
Cov.:
31
AF XY:
0.0224
AC XY:
1662
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.00520
AC:
216
AN:
41520
American (AMR)
AF:
0.0150
AC:
228
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
0.0320
AC:
111
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5168
South Asian (SAS)
AF:
0.0125
AC:
60
AN:
4818
European-Finnish (FIN)
AF:
0.0297
AC:
314
AN:
10580
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0359
AC:
2442
AN:
67994
Other (OTH)
AF:
0.0190
AC:
40
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
171
342
512
683
854
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0129
Hom.:
6
Bravo
AF:
0.0223
Asia WGS
AF:
0.00779
AC:
27
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jul 10, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.8
DANN
Benign
0.76
PhyloP100
0.063
PromoterAI
-0.022
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs118052093; hg19: chr16-21689571; API